-
European Patent Office grants patent on the use of human egg cells
Testbiotech sees clash with ethical boundaries
In July 2009 the European Patent Office granted the Swiss company Merck Serono a patent on the ripening process of human egg cells including their use in in vitro fertilisation treatment. Once the patent was granted Merck Serono not only had a monopoly on the egg ripening process but also exclusive rights on the usage…
-
Leading European Food Safety Authority Staff Member Moves into Industry
Scientific coordinator of GMO panel moves to Syngent
Munich/ Parma – A leading staff member of the European Food Safety Authority (EFSA) has quit to work in industry. Suzy Renckens, scientific coordinator of the GMO panel, officially represented Syngenta in an expert hearing at EU level in 2008. She now holds a position there as Head of Biotech Regulatory Affairs for Europe, Africa…
-
Testbiotech starts EFSA GMO Watch
Initiative for more transparency in the risk assessment of genetically engineered plants
Today Testbiotech starts its EFSA GMO Watch Newsletter project. The newsletter will give an overview of the European Food Safety Authority’s (EFSA) activities concerning genetically engineered plants. Current reports from the EFSA and new applications from industry are the focus of this information service. The newsletter is directed towards journalists and interested parties. Testbiotech e.…